FDA rejects MDMA therapy for PTSD: a blow for supporters of psychedelic treatments.


FDA rejects MDMA therapy for PTSD: a blow for supporters of psychedelic treatments.

Reading

Read this text and listen to it at the same time. If you don’t know a word click it to see explanation, hear pronunciation or add it to vocabulary.
FDA rejects MDMA therapy for PTSD: a blow for supporters of psychedelic treatments.

The FDA did not approve MDMA for PTSD treatment. This is a setback for groups wanting to use psychedelics for mental health.

The FDA wants more research and a new study before approving MDMA. Lykos, the drug maker, is disappointed but will do more research.


Questions

Answer the questions to the text. Speak or write, you choose. AI will assess your answers.

Did the FDA approve MDMA for PTSD treatment?

No, the FDA did not approve MDMA for PTSD treatment.

What does the FDA want before approving MDMA?

The FDA wants more research and a new study before approving MDMA.

How does Lykos feel about the FDA's decision?

Lykos is disappointed but will do more research.


Describe the article image

Look at the article image and describe what you see on it. You may either speak or write your answer there.


Discussion

Discuss this article with your AI tutor to practice. Your tutor will help you with vocabulary and grammar.

Read a new article every day and
discuss it with AI at lingolette.com
All content and tasks are generated by AI inspired by a real publication.